← All trials
NCT01712425
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2012
- Primary completion
- Oct 1, 2015
- Completion date
- Oct 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- IrsiCaixaLead sponsor
- Institut de Recerca de la Sida IrsiCaixa-HIVACATOverall official - principal investigator
- Institut de Recerca de la Sida IrsiCaixa-HIVACATStudy chair
- Fundacio Lluita Contra la SIDACollaborator
- University of BarcelonaCollaborator
- HIVACATCollaborator
- University of OxfordCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.